VAERS reports by lot

Moderna COVID-19 lot 031LZ0A: VAERS reports

20 VAERS reports list lot 031LZ0A as a Moderna COVID-19 vaccine, received between 2021-02-11 and 2023-01-13. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
20
Reports
0%
Marked serious
0
With a death outcome
10
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)2025%
Injection-site / Local reaction1519%
Neurological911%
Musculoskeletal911%
Dermatological (non-injection-site)79%
Gastrointestinal68%
Cardiac / Cardiovascular45%
Autoimmune / Immune-mediated34%
Allergic / Anaphylactic34%
Respiratory34%

Where reports came from

U.S. state of the reporter, where given (top 12).

North Carolina4
New Jersey3
Idaho2
Georgia2
Rhode Island1
Wisconsin1
Arizona1
Oregon1
Florida1
Nevada1
Illinois1
Pennsylvania1

Reports by month received

2021-024
2021-031
2021-061
2021-071
2021-086
2021-091
2022-021
2022-041
2022-113
2023-011

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.